GlassScriptPhysician profile
John Vincent Tiberi
NPI 1295929826
$348,227.99
in general payments reported to CMS, 2019-2025
12 companies · $23K in 2025
The $23K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113K · 2020: $59K · 2021: $62K · 2022: $25K · 2023: $50K · 2024: $16K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $66K · Travel and Lodging: $18K · Food and Beverage: $5,063 · Education: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $65,875.00 |
| Travel and Lodging | $18,216.03 |
| Food and Beverage | $5,062.51 |
| Education | $516.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $328,282.05 | 2019-2025 | Mako, Aequalis, Gmrs |
| Techmah Medical, LLC | $9,700.80 | 2019-2020 | |
| Think Surgical, INC. | $4,132.05 | 2025 | |
| Lima USA, INC. | $1,861.67 | 2019-2020 | |
| Microport Orthopedics INC | $1,643.37 | 2023-2024 | Mpo Medial Pivot Knee |
| Medacta USA, INC. | $1,434.67 | 2022-2025 | Gmk Sphere, Mpact |
| Smith+Nephew, INC. | $686.46 | 2019-2025 | N/A, Cap-Fix |
| Depuy Synthes Sales INC. | $210.22 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $170.00 | 2019-2025 | Mymobility Platform |
| Innovation Technologies INC | $62.50 | 2021 | |
| Dynasplint Systems INC. | $28.06 | 2025 | Dynasplint |
| Ethicon US, LLC | $16.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tiberi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.